Literature DB >> 21879374

Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders.

Marsha A Raebel1, Jennifer L Ellis, Nikki M Carroll, Elizabeth A Bayliss, Brandy McGinnis, Emily B Schroeder, Susan Shetterly, Stan Xu, John F Steiner.   

Abstract

BACKGROUND: Information comparing characteristics of patients who do and do not pick up their prescriptions is sparse, in part because adherence measured using pharmacy claims databases does not include information on patients who never pick up their first prescription, that is, patients with primary non-adherence. Electronic health record medication order entry enhances the potential to identify patients with primary non-adherence, and in organizations with medication order entry and pharmacy information systems, orders can be linked to dispensings to identify primarily non-adherent patients.
OBJECTIVE: This study aims to use database information from an integrated system to compare patient, prescriber, and payment characteristics of patients with primary non-adherence and patients with ongoing dispensings of newly initiated medications for hypertension, diabetes, and/or hyperlipidemia.
DESIGN: This is a retrospective observational cohort study. PARTICIPANTS (OR PATIENTS OR SUBJECTS): Participants of this study include patients with a newly initiated order for an antihypertensive, antidiabetic, and/or antihyperlipidemic within an 18-month period. MAIN MEASURES: Proportion of patients with primary non-adherence overall and by therapeutic class subgroup. Multivariable logistic regression modeling was used to investigate characteristics associated with primary non-adherence relative to ongoing dispensings. KEY
RESULTS: The proportion of primarily non-adherent patients varied by therapeutic class, including 7% of patients ordered an antihypertensive, 11% ordered an antidiabetic, 13% ordered an antihyperlipidemic, and 5% ordered medications from more than one of these therapeutic classes within the study period. Characteristics of patients with primary non-adherence varied across therapeutic classes, but these characteristics had poor ability to explain or predict primary non-adherence (models c-statistics = 0.61-0.63).
CONCLUSIONS: Primary non-adherence varies by therapeutic class. Healthcare delivery systems should pursue linking medication orders with dispensings to identify primarily non-adherent patients. We encourage conduct of research to determine interventions successful at decreasing primary non-adherence, as characteristics available from databases provide little assistance in predicting primary non-adherence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21879374      PMCID: PMC3250550          DOI: 10.1007/s11606-011-1829-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  35 in total

1.  The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know.

Authors:  Rajesh Balkrishnan
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

2.  New prescription medication gaps: a comprehensive measure of adherence to new prescriptions.

Authors:  Andrew J Karter; Melissa M Parker; Howard H Moffet; Ameena T Ahmed; Julie A Schmittdiel; Joe V Selby
Journal:  Health Serv Res       Date:  2009-06-03       Impact factor: 3.402

3.  Improving the validity of determining medication adherence from electronic health record medications orders.

Authors:  Nikki M Carroll; Jennifer L Ellis; Capp F Luckett; Marsha A Raebel
Journal:  J Am Med Inform Assoc       Date:  2011-05-25       Impact factor: 4.497

4.  Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.

Authors:  Elizabeth A Walker; Mark Molitch; M Kaye Kramer; Steven Kahn; Yong Ma; Sharon Edelstein; Kellie Smith; Mariana Kiefer Johnson; Abbas Kitabchi; Jill Crandall
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

5.  Impact of medication adherence on hospitalization risk and healthcare cost.

Authors:  Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

Review 6.  Predictors of nonadherence to statins: a systematic review and meta-analysis.

Authors:  Devin M Mann; Mark Woodward; Paul Muntner; Louise Falzon; Ian Kronish
Journal:  Ann Pharmacother       Date:  2010-08-11       Impact factor: 3.154

7.  Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study.

Authors:  Chien-Wen Tseng; Edward F Tierney; Robert B Gerzoff; R Adams Dudley; Beth Waitzfelder; Ronald T Ackermann; Andrew J Karter; John Piette; Jesse C Crosson; Quyen Ngo-Metzger; Richard Chung; Carol M Mangione
Journal:  Diabetes Care       Date:  2007-11-13       Impact factor: 19.112

8.  Comparison of drug adherence rates among patients with seven different medical conditions.

Authors:  Becky A Briesacher; Susan E Andrade; Hassan Fouayzi; K Arnold Chan
Journal:  Pharmacotherapy       Date:  2008-04       Impact factor: 4.705

9.  Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension.

Authors:  John F Steiner; P Michael Ho; Brenda L Beaty; L Miriam Dickinson; Rebecca Hanratty; Chan Zeng; Heather M Tavel; Edward P Havranek; Arthur J Davidson; David J Magid; Raymond O Estacio
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-08-11

10.  Impact of prescription size on statin adherence and cholesterol levels.

Authors:  Holly A Batal; Mori J Krantz; Rita A Dale; Phillip S Mehler; John F Steiner
Journal:  BMC Health Serv Res       Date:  2007-10-25       Impact factor: 2.655

View more
  44 in total

1.  Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques.

Authors:  Jessica M Franklin; William H Shrank; Joyce Lii; Alexis K Krumme; Olga S Matlin; Troyen A Brennan; Niteesh K Choudhry
Journal:  Health Serv Res       Date:  2015-04-16       Impact factor: 3.402

2.  Interventions aimed at improving performance on medication adherence metrics.

Authors:  Brandy McGinnis; Yardlee Kauffman; Kari L Olson; Daniel M Witt; Marsha A Raebel
Journal:  Int J Clin Pharm       Date:  2014-02

3.  Capsule Commentary on Franklin et al., Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA.

Authors:  John-Michael Gamble
Journal:  J Gen Intern Med       Date:  2018-11       Impact factor: 5.128

4.  Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.

Authors:  Marsha A Raebel; Wendy Dyer; Gregory A Nichols; Glenn K Goodrich; Julie A Schmittdiel
Journal:  Pharmacotherapy       Date:  2017-09-12       Impact factor: 4.705

5.  Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.

Authors:  Gregory S Calip; Joann G Elmore; Denise M Boudreau
Journal:  Breast Cancer Res Treat       Date:  2016-11-08       Impact factor: 4.872

6.  Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study.

Authors:  Julie A Schmittdiel; Marsha A Raebel; Wendy Dyer; Stanley Xu; Glenn K Goodrich; Emily B Schroeder; Jodi B Segal; Patrick J O' Connor; Gregory A Nichols; Jean M Lawrence; H Lester Kirchner; Andy J Karter; Jennifer Elston Lafata; Melissa G Butler; John F Steiner
Journal:  J Am Pharm Assoc (2003)       Date:  2014 Jul-Aug

7.  Improving adherence with medication: a selective literature review based on the example of hypertension treatment.

Authors:  Jan Matthes; Christian Albus
Journal:  Dtsch Arztebl Int       Date:  2014-01-24       Impact factor: 5.594

8.  Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.

Authors:  Jennifer Elston Lafata; Andrew J Karter; Patrick J O'Connor; Heather Morris; Julie A Schmittdiel; Scott Ratliff; Katherine M Newton; Marsha A Raebel; Ram D Pathak; Abraham Thomas; Melissa G Butler; Kristi Reynolds; Beth Waitzfelder; John F Steiner
Journal:  J Gen Intern Med       Date:  2016-02       Impact factor: 5.128

9.  Primary non-adherence to bisphosphonates in an integrated healthcare setting.

Authors:  K Reynolds; P Muntner; T C Cheetham; T N Harrison; D E Morisky; S Silverman; D T Gold; S S Vansomphone; R Wei; C D O'Malley
Journal:  Osteoporos Int       Date:  2013-04-18       Impact factor: 4.507

10.  Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases.

Authors:  Marsha A Raebel; Julie Schmittdiel; Andrew J Karter; Jennifer L Konieczny; John F Steiner
Journal:  Med Care       Date:  2013-08       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.